Keywords: risperdal, outperforms, zyprexa, study, battle, between, janssen

Risperdal Outperforms Zyprexa In US Study

Article | 06 November 1998

Print This

The battle between Janssen and Eli Lilly in the antipsychotic market hasstepped up a gear with the announcement of a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in